ABOUT THIS FEED
The AI in Medicine RSS feed, currently aggregated through a library portal, focuses on the growing role of artificial intelligence in healthcare. Articles in this feed highlight clinical applications such as diagnostic imaging, predictive analytics, drug discovery, and personalized medicine. Readers can expect updates on both academic research and practical deployments in hospitals and health systems. While still serving as a stand-in until more specialized feeds are available, it offers valuable insights into how AI is transforming medical practice. With posts appearing several times per week, the feed is particularly useful for clinicians, researchers, and healthcare professionals seeking to understand the practical benefits and challenges of adopting AI in medicine. It provides a focused lens on one of the most impactful domains of AI application.
- Discontinuation of Levothyroxine—Reply
In Reply We thank Dr Kaneda for this clinically relevant question dedicated to optimize thyroid treatment in adults aged 60 years or older. Given the debate about lifelong levothyroxine use in adults aged 60 years or older, we conducted an open-label, single-group, prospective study to determine the proportion of people who took thyroxine who could discontinue treatment while maintaining acceptable thyroid function.
- Intracellular Bacterial Persistence in Preventing Surgical Site Infections in Tibial Fractures—Reply
In Reply We thank Chen and colleagues for their insights into potential reasons why the TOBRA trial found that tobramycin plus vancomycin powder applied locally in the wound of periarticular tibial fractures at the time of definitive fixation did not reduce risk of deep surgical site infection compared with vancomycin alone. Notably, in the subgroup of 302 patients with open tibial fractures, tobramycin plus vancomycin was associated with increased deep surgical site infection risk (hazard ratio, 2.08; 95% CI, 1.06-4.37), raising the possibility of harm in this high-risk group.
- Classic Hodgkin Lymphoma: A Review
This Review discusses Hodgkin lymphoma and summarizes current evidence regarding the pathogenesis, epidemiology, diagnosis, and management of classic Hodgkin lymphoma in adults aged 18 years and older.
- The Supreme Court and Public Health Regulation
This Viewpoint summarizes the ways in which federal health agencies and state-level safeguards work in parallel to ensure public health and highlights how 3 recent Supreme Court rulings have reduced the independence of federal agencies, expanded political control over them, and curtailed state-level protections meant to challenge and supplement federal standards.
- Peanut Allergen Exposure—Reply
In Reply We thank Dr Yanagisawa and colleagues for their thoughtful correspondence highlighting blood transfusion as a theoretical but underrecognized route of peanut allergen exposure in response to our JAMA Insights article.
- Audio Highlights August 14, 2026
Listen to the JAMA Editor’s Summary for an overview and discussion of the important articles appearing in JAMA.
- Osimertinib With or Without Chemotherapy in Advanced Non–Small Cell Lung Cancer With EGFR Variations in Concurrent TP53 Mutations Research Summary
This trial compared the efficacy and safety of osimertinib + chemotherapy vs osimertinib alone in patients with epidermal growth factor receptor (EGFR)–mutated advanced non–small cell lung cancer (NSCLC) harboring TP53 mutations.
- Wildfire Smoke Linked to Increase in ED Visits for Migraine and Headache
Wildfire smoke may be associated with an uptick in emergency department (ED) visits for migraine and other primary headache, according to a study published in JAMA Network Open.
- Drinking Water Contaminants Associated With Uterine Cancer Risk
Common public drinking water contaminants may be linked to an increased risk of uterine cancer, a study published in JAMA Network Open found.
- Ebola Outbreak Intensifies
The Ebola outbreak in the Democratic Republic of the Congo (DRC) is intensifying, according to the World Health Organization (WHO).